SC 13D/A | 2019-12-20 | BAKER BROS. ADVISORS LP | Neoleukin Therapeutics, Inc. | 3,802,740 | 10.0% | EDGAR |
SC 13D/A | 2019-11-18 | BAKER BROS. ADVISORS LP | Neoleukin Therapeutics, Inc. | 11,305,679 | 29.5% | EDGAR |
SC 13D/A | 2019-08-13 | BAKER BROS. ADVISORS LP | Neoleukin Therapeutics, Inc. | 11,359,679 | 40.3% | EDGAR |
SC 13D/A | 2019-08-07 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 11,359,679 | 48.2% | EDGAR |
SC 13G/A | 2019-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | AQUINOX PHARMACEUTICALS, INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2019-02-14 | EcoR1 Capital, LLC | AQUINOX PHARMACEUTICALS, INC | 2,265,880 | 9.6% | EDGAR |
SC 13G/A | 2019-01-25 | FRANKLIN RESOURCES INC | AQUINOX PHARMACEUTICALS, INC | 0 | 0.0% | EDGAR |
SC 13G | 2018-07-16 | EcoR1 Capital, LLC | AQUINOX PHARMACEUTICALS, INC | 1,758,973 | 7.5% | EDGAR |
SC 13G/A | 2018-07-10 | PRICE T ROWE ASSOCIATES INC /MD/ | AQUINOX PHARMACEUTICALS, INC | 1,350,000 | 5.7% | EDGAR |
SC 13G/A | 2018-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | AQUINOX PHARMACEUTICALS, INC | 3,375,130 | 14.3% | EDGAR |
SC 13G/A | 2018-02-14 | RA CAPITAL MANAGEMENT, LLC | AQUINOX PHARMACEUTICALS, INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2018-02-05 | FRANKLIN RESOURCES INC | AQUINOX PHARMACEUTICALS, INC | 1,334,607 | 5.7% | EDGAR |
SC 13G/A | 2018-01-09 | BlackRock Inc. | AQUINOX PHARMACEUTICALS, INC | 1,014,297 | 4.3% | EDGAR |
SC 13D/A | 2017-03-27 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 10,934,154 | 46.7% | EDGAR |
SC 13G/A | 2017-02-14 | RA Capital Healthcare Fund LP | AQUINOX PHARMACEUTICALS, INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-02-14 | RA CAPITAL MANAGEMENT, LLC | AQUINOX PHARMACEUTICALS, INC | 2,191,977 | 9.4% | EDGAR |
SC 13G/A | 2017-02-14 | Visium Asset Management, LP | AQUINOX PHARMACEUTICALS, INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-02-09 | FRANKLIN RESOURCES INC | AQUINOX PHARMACEUTICALS, INC | 1,392,245 | 5.9% | EDGAR |
SC 13G/A | 2017-02-06 | PRICE T ROWE ASSOCIATES INC /MD/ | AQUINOX PHARMACEUTICALS, INC | 3,400,397 | 14.5% | EDGAR |
SC 13G/A | 2017-01-19 | BlackRock Inc. | AQUINOX PHARMACEUTICALS, INC | 1,592,399 | 6.8% | EDGAR |